14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:LMNL
Delisted

Liminal Biosciences Inc. Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$8.50
+0 (+0%)
At Close: Dec 22, 2023
Forecast Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Currently predicting for Mon, 6 May 2024

LMNL Predictions History

2 years ago
 JS predicted that LMNL for 2021-06-14 is going $4.82 (-0.41%)

3 years ago
 JS predicted that LMNL for 2021-01-19 is going $5.66 (3.47%)

3 years ago
 Longv587 predicted that LMNL for 2021-01-19 is going $5.97 (9.14%)

Rank:
Click to get the best stock tips daily for free!

About Liminal Biosciences Inc.

Liminal Biosciences. Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the treatment of idiopathic pulmonary, liver, cardiac, or skin fibrosis with fezagepras or related derivatives ... LMNL Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT